Watch List: EMC Corporation (NYSE:EMC), Chimera Investment Corporation (NYSE:CIM), Watsco Inc. (NYSE:WSO), BioDelivery Sciences International, Inc. (NASDAQ:BDSI), MacroGenics, Inc. (NASDAQ:MGNX)

Technology Stocks News 11

EMC Corporation(NYSE:EMC)‘s stock had its “buy” rating reissued by equities research analysts at Jefferies Group in a research note issued to investors on Thursday. They currently have a $36.00 price objective on the stock, down from their previous price objective of $37.00. EMC Corporation (NYSE:EMC) belongs to Technology sector. Its net profit margin is 12.40% and weekly performance is 1.34%. On last trading day company shares ended up $29.43. EMC Corporation (NYSE:EMC) distance from 50-day simple moving average (SMA50) is 2.70%.

On Nov 10, Chimera Investment Corporation (NYSE:CIM) announced its financial results for the quarter ended September 30, 2014. The Company reported net income for the quarter ended September 30, 2014 of $378 million or $0.37 per average share as compared to net income for the quarter ended September 30, 2013 of $67 million or $0.07 per average share. Net income for the nine months ended September 30, 2014 was $583 million or $0.57 per average share as compared to net income for the nine months ended September 30, 2013 of $290 million or $0.28 per average share. Chimera Investment Corporation (NYSE:CIM) shares increased 0.31% in last trading session and ended the day at $3.24. CIM Gross Margin is 77.60% and its return on assets is 4.20%. Chimera Investment Corporation (NYSE:CIM) quarterly performance is 3.18%.

Watsco Inc. (NYSE:WSO) present at the Baird 2014 Industrial Conference at the Four Seasons Hotel in Chicago. The event begin at 11:30 AM ET on November 12, 2014. On 12 November, Watsco Inc. (NYSE:WSO) shares increased 0.49% and was closed at $102.96. WSO EPS growth in last 5 year was 12.00%. Watsco Inc. (NYSE:WSO) year to date (YTD) performance is 9.49%.

On Nov. 5, BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014. At the end of the third quarter of 2014, BDSI had $85.8 million in cash, compared to $23.2 million on December 31, 2013 . BioDelivery Sciences International, Inc. (NASDAQ:BDSI) ended the last trading day at $15.95. Company weekly volatility is calculated as 5.84% and price to cash ratio as 10.43. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) showed a weekly performance of -2.15%.

MacroGenics, Inc. (NASDAQ:MGNX provided a corporate progress update and reported financial results for the quarter ended September 30, 2014. Total revenues, consisting primarily of revenue from collaborative research, were $18.4 million for the quarter ended September 30, 2014, compared to $20.2 million for the quarter ended September 30, 2013. Collaborative research revenue includes the recognition of deferred revenue from payments received in previous periods as well as payments received during the quarter. MacroGenics, Inc. (NASDAQ:MGNX) shares increased 12.43% in last trading session and ended the day at $23.78. MGNX return on assets is -10.60%. MacroGenics, Inc. (NASDAQ:MGNX) quarterly performance is 15.77%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone